News
Quatrefolic® Seminar: Anemia
18 November 2024
Anemia is a worldwide public health issue, and one-fourth of the global population is estimated to be anemic, with cases increasing rapidly in women.
Folate supplementation, such as Quatrefolic®, can reduce the risk of anemia, supporting red blood formation.
Over half a billion women between the ages of 15 and 49 made up the global anemia prevalence in 2019, including women of reproductive age, pregnant women, and nonpregnant.
There was an increase of 420 million cases in 2021, the highest number in three decades. Data revealed that anemia was 23.7% in Indonesia and 32.0% among individuals aged 15–24.
Quatrefolic®, the natural approach to addressing Anemia
Among the various types of anemia, the most common cause is nutritional deficiencies, where concentrations of iron and vitamins involved in red blood cell production or maintenance are insufficient to meet those demands.
Folate-deficiency anemia is characterized by abnormally large red blood cells, which are produced in reduced numbers, leading to anemia.
Quatrefolic®, the active folate, has been recognized by the European Food Safety Authority for supporting normal blood formation and reducing fatigue and tiredness.
